1
|
Mukherjee P, Rahaman SG, Goswami R, Dutta B, Mahanty M, Rahaman SO. Role of mechanosensitive channels/receptors in atherosclerosis. Am J Physiol Cell Physiol 2022; 322:C927-C938. [PMID: 35353635 PMCID: PMC9109792 DOI: 10.1152/ajpcell.00396.2021] [Citation(s) in RCA: 9] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2021] [Revised: 03/09/2022] [Accepted: 03/22/2022] [Indexed: 11/22/2022]
Abstract
Mechanical forces are critical physical cues that can affect numerous cellular processes regulating the development, tissue maintenance, and functionality of cells. The contribution of mechanical forces is especially crucial in the vascular system where it is required for embryogenesis and for maintenance of physiological function in vascular cells including aortic endothelial cells, resident macrophages, and smooth muscle cells. Emerging evidence has also identified a role of these mechanical cues in pathological conditions of the vascular system such as atherosclerosis and associated diseases like hypertension. Of the different mechanotransducers, mechanosensitive ion channels/receptors are gaining prominence due to their involvement in numerous physiological and pathological conditions. However, only a handful of potential mechanosensory ion channels/receptors have been shown to be involved in atherosclerosis, and their precise role in disease development and progression remains poorly understood. Here, we provide a comprehensive account of recent studies investigating the role of mechanosensitive ion channels/receptors in atherosclerosis. We discuss the different groups of mechanosensitive proteins and their specific roles in inflammation, endothelial dysfunction, macrophage foam cell formation, and lesion development, which are crucial for the development and progression of atherosclerosis. Results of the studies discussed here will help in developing an understanding of the current state of mechanobiology in vascular diseases, specifically in atherosclerosis, which may be important for the development of innovative and targeted therapeutics for this disease.
Collapse
Affiliation(s)
- Pritha Mukherjee
- Department of Nutrition and Food Science, University of Maryland, College Park, Maryland
| | | | - Rishov Goswami
- Department of Nutrition and Food Science, University of Maryland, College Park, Maryland
| | - Bidisha Dutta
- Department of Nutrition and Food Science, University of Maryland, College Park, Maryland
| | - Manisha Mahanty
- Department of Nutrition and Food Science, University of Maryland, College Park, Maryland
| | - Shaik O Rahaman
- Department of Nutrition and Food Science, University of Maryland, College Park, Maryland
| |
Collapse
|
2
|
Yaker L, Tebani A, Lesueur C, Dias C, Jung V, Bekri S, Guerrera IC, Kamel S, Ausseil J, Boullier A. Extracellular Vesicles From LPS-Treated Macrophages Aggravate Smooth Muscle Cell Calcification by Propagating Inflammation and Oxidative Stress. Front Cell Dev Biol 2022; 10:823450. [PMID: 35356285 PMCID: PMC8959646 DOI: 10.3389/fcell.2022.823450] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2021] [Accepted: 02/09/2022] [Indexed: 12/29/2022] Open
Abstract
Background: Vascular calcification (VC) is a cardiovascular complication associated with a high mortality rate among patients with diseases such as atherosclerosis and chronic kidney disease. During VC, vascular smooth muscle cells (VSMCs) undergo an osteogenic switch and secrete a heterogeneous population of extracellular vesicles (EVs). Recent studies have shown involvement of EVs in the inflammation and oxidative stress observed in VC. We aimed to decipher the role and mechanism of action of macrophage-derived EVs in the propagation of inflammation and oxidative stress on VSMCs during VC. Methods: The macrophage murine cell line RAW 264.7 treated with lipopolysaccharide (LPS-EK) was used as a cellular model for inflammatory and oxidative stress. EVs secreted by these macrophages were collected by ultracentrifugation and characterized by transmission electron microscopy, cryo-electron microscopy, nanoparticle tracking analysis, and the analysis of acetylcholinesterase activity, as well as that of CD9 and CD81 protein expression by western blotting. These EVs were added to a murine VSMC cell line (MOVAS-1) under calcifying conditions (4 mM Pi—7 or 14 days) and calcification assessed by the o-cresolphthalein calcium assay. EV protein content was analyzed in a proteomic study and EV cytokine content assessed using an MSD multiplex immunoassay. Results: LPS-EK significantly decreased macrophage EV biogenesis. A 24-h treatment of VSMCs with these EVs induced both inflammatory and oxidative responses. LPS-EK-treated macrophage-derived EVs were enriched for pro-inflammatory cytokines and CAD, PAI-1, and Saa3 proteins, three molecules involved in inflammation, oxidative stress, and VC. Under calcifying conditions, these EVs significantly increase the calcification of VSMCs by increasing osteogenic markers and decreasing contractile marker expression. Conclusion: Our results show that EVs derived from LPS-EK–treated-macrophages are able to induce pro-inflammatory and pro-oxidative responses in surrounding cells, such as VSMCs, thus aggravating the VC process.
Collapse
Affiliation(s)
- Linda Yaker
- MP3CV-UR7517, CURS-University of Picardie Jules Verne, Amiens, France
| | - Abdellah Tebani
- INSERM U1245, CHU Rouen, Normandie University, UNIROUEN, Rouen, France
- Department of Metabolic Biochemistry, Rouen University Hospital, Rouen, France
| | - Céline Lesueur
- INSERM U1245, CHU Rouen, Normandie University, UNIROUEN, Rouen, France
| | - Chloé Dias
- Infinity, INSERM UMR1291, CNRS UMR5051, University of Toulouse III, Toulouse, France
| | - Vincent Jung
- INSERM US24/CNRS UAR3633, Proteomic Platform Necker, University of Paris—Federative Research Structure Necker, Paris, France
| | - Soumeya Bekri
- INSERM U1245, CHU Rouen, Normandie University, UNIROUEN, Rouen, France
- Department of Metabolic Biochemistry, Rouen University Hospital, Rouen, France
| | - Ida Chiara Guerrera
- INSERM US24/CNRS UAR3633, Proteomic Platform Necker, University of Paris—Federative Research Structure Necker, Paris, France
| | - Saïd Kamel
- MP3CV-UR7517, CURS-University of Picardie Jules Verne, Amiens, France
- Laboratory of Biochemistry, CHU Amiens-Picardie, Amiens, France
| | - Jérôme Ausseil
- Infinity, INSERM UMR1291, CNRS UMR5051, University of Toulouse III, Toulouse, France
- Service de Biochimie, Institut Fédératif de Biologie, CHU Toulouse, Toulouse, France
| | - Agnès Boullier
- MP3CV-UR7517, CURS-University of Picardie Jules Verne, Amiens, France
- Laboratory of Biochemistry, CHU Amiens-Picardie, Amiens, France
- *Correspondence: Agnès Boullier,
| |
Collapse
|
3
|
Toita R, Asai D, Otani K, Kawano T, Murata M, Kang J. Suppression of Lysophosphatidylcholine‐Induced Human Aortic Smooth Muscle Cell Calcification by Protein Kinase A Inhibition. Lipids 2019; 54:465-470. [DOI: 10.1002/lipd.12178] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2019] [Revised: 05/31/2019] [Accepted: 06/03/2019] [Indexed: 11/07/2022]
Affiliation(s)
- Riki Toita
- Biomedical Research InstituteNational Institute of Advanced Industrial Science and Technology (AIST) 1‐8‐31 Midorigaoka, Ikeda, Osaka, 563‐8577 Japan
- AIST‐Osaka University Advanced Photonics and Biosensing Open Innovation Laboratory 2‐1 Yamadaoka, Suita, Osaka, 565‐0871 Japan
| | - Daisuke Asai
- Department of MicrobiologySt. Marianna University School of Medicine 2‐16‐1 Sugao, Miyamae, Kawasaki, 216‐8511 Japan
| | - Kentaro Otani
- Department of Regenerative Medicine and Tissue EngineeringNational Cerebral and Cardiovascular Center Research Institute 5‐7‐1 Fujishiro‐dai, Suita, Osaka, 565‐8565 Japan
| | - Takahito Kawano
- Center for Advanced Medical InnovationKyushu University 3‐1‐1 Maidashi, Higashi‐ku, Fukuoka, 812‐8582 Japan
| | - Masaharu Murata
- Center for Advanced Medical InnovationKyushu University 3‐1‐1 Maidashi, Higashi‐ku, Fukuoka, 812‐8582 Japan
| | - Jeong‐Hun Kang
- Division of Biopharmaceutics and PharmacokineticsNational Cerebral and Cardiovascular Center Research Institute 5‐7‐1 Fujishiro‐dai, Suita, Osaka, 565‐8565, Japan
| |
Collapse
|
4
|
Wang Y, Wang Y, Li GR. TRPC1/TRPC3 channels mediate lysophosphatidylcholine-induced apoptosis in cultured human coronary artery smooth muscles cells. Oncotarget 2018; 7:50937-50951. [PMID: 27472391 PMCID: PMC5239449 DOI: 10.18632/oncotarget.10853] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2016] [Accepted: 07/09/2016] [Indexed: 02/05/2023] Open
Abstract
The earlier study showed that lysophosphatidylcholine (lysoPC) induced apoptosis in human coronary artery smooth muscle cells (SMCs); however, the related molecular mechanisms are not fully understood. The present study investigated how lysoPC induces apoptosis in cultured human coronary artery SMCs using cell viability assay, flow cytometry, confocal microscopy, and molecular biological approaches. We found that lysoPC reduced cell viability in human coronary artery SMCs by eliciting a remarkable Ca2+ influx. The effect was antagonized by La3+, SKF-96365, or Pyr3 as well as by silencing TRPC1 or TRPC3. Co-immunoprecipitation revealed that TRPC1 and TRPC3 had protein-protein interaction. Silencing TRPC1 or TRPC3 countered the lysoPC-induced increase of Ca2+ influx and apoptosis, and the pro-apoptotic proteins Bax and cleaved caspase-3 and decrease of the anti-apoptotic protein Bcl-2 and the survival kinase pAkt. These results demonstrate the novel information that TRPC1/TRPC3 channels mediate lysoPC-induced Ca2+ influx and apoptosis via activating the pro-apoptotic proteins Bax and cleaved caspase-3 and inhibiting the anti-apoptotic protein Bcl-2 and the survival kinase pAkt in human coronary artery SMCs, which implies that TRPC1/TRC3 channels may be the therapeutic target of lysoPC-induced disorders such as atherosclerosis.
Collapse
Affiliation(s)
- Yuan Wang
- Xiamen Cardiovascular Hospital, Medical School of Xiamen University, Xiamen, Fujian, China.,Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China
| | - Yan Wang
- Xiamen Cardiovascular Hospital, Medical School of Xiamen University, Xiamen, Fujian, China
| | - Gui-Rong Li
- Xiamen Cardiovascular Hospital, Medical School of Xiamen University, Xiamen, Fujian, China.,Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Pokfulam, Hong Kong, China
| |
Collapse
|
5
|
Yeager ME, Colvin KL, Everett AD, Stenmark KR, Ivy DD. Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension. Proteomics Clin Appl 2012; 6:257-67. [PMID: 22653875 DOI: 10.1002/prca.201100078] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
PURPOSE The prognosis for children with IPAH unresponsive to therapy is poor. We investigated the plasma proteome for a molecular basis of good versus poor outcome to long-term vasodilator therapy. EXPERIMENTAL DESIGN Plasma was collected at baseline or shortly after therapy initiation and following chronic vasodilator therapy, then divided into those with good outcome (n = 8), and those with a poor outcome (n = 7). To identify proteins unique to either outcome, we used differential gel electrophoresis and mass spectrometry. Results were confirmed by commercial enzyme-linked immunosorbent assay. RESULTS Before and after therapy, SAA-4 was 4-fold lower in those with good outcome compared to those with poor outcome, while serum paraoxonase/arylesterase-1 was increased 2-fold in those with good outcome versus poor outcome. After therapy, haptoglobin and hemopexin were 1.45- and 1.8-fold lower, respectively, in those with a good versus poor outcome. Among those with a good outcome, SAP was 1.3-fold lower prior to therapy. CONCLUSIONS AND CLINICAL RELEVANCE SAP and SAA-4 regulate circulating mononuclear phagocytes. As such, they may contribute to the differential response to chronic vasodilator therapy in the context of inflammation in IPAH.
Collapse
Affiliation(s)
- Michael E Yeager
- Department of Pediatric Critical Care, University of Colorado Denver, Denver, CO 80045, USA.
| | | | | | | | | |
Collapse
|
6
|
Zhang H, Zhang J, Shen D, Zhang L, He F, Dang Y, Li L. Regression of atherosclerosis in apolipoprotein E-deficient mice by lentivirus-mediated gene silencing of lipoprotein-associated phospholipase A2. Biochem Biophys Res Commun 2012; 427:557-62. [PMID: 23022183 DOI: 10.1016/j.bbrc.2012.09.096] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2012] [Accepted: 09/18/2012] [Indexed: 11/17/2022]
Abstract
Overexpression of lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is implicated in atherosclerosis. We tested the hypothesis that lentivirus-mediated Lp-PLA(2) silencing could inhibit atherosclerosis in apolipoprotein E-deficient mice. Sixty eight apolipoprotein E-deficient mice were fed a high-fat diet and a constrictive collar was placed around the left carotid artery to induce plaque formation. The mice were randomly divided into control, negative control (NC) and RNA interference (RNAi) groups. Lp-PLA(2) RNAi or scrambled NC lentivirus viral suspensions were constructed and transfected into the carotid plaques 8 weeks after surgery; the control group was administered saline. The carotid plaques were assessed 7 weeks later using hematoxylin and eosin, Masson's trichrome and oil red O staining; plasma and lesion inflammatory gene expression were examined using ELISAs and real-time PCR. Seven weeks after transfection, the serum concentration and plaque mRNA expression of Lp-PLA(2) was significantly lower in the RNAi group, and lead to reduced local and systemic inflammatory gene expression. Lp-PLA(2) RNAi also ameliorated plaque progression, reduced the plaque lipid content and increased the plaque collagen content. The effects of Lp-PLA(2) RNAi were independent of serum lipoprotein levels, as the triglyceride and total cholesterol levels of the control, NC and RNAi groups were not significantly different. These findings support the hypothesis that lentivirus-mediated Lp-PLA(2) gene silencing has therapeutic potential to inhibit atherosclerosis and increase plaque stability, without altering the plasma lipoprotein profile.
Collapse
Affiliation(s)
- Hui Zhang
- Department of Cardiology, The First Affliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, PR China
| | | | | | | | | | | | | |
Collapse
|
7
|
Thilo F, Vorderwülbecke BJ, Marki A, Krueger K, Liu Y, Baumunk D, Zakrzewicz A, Tepel M. Pulsatile Atheroprone Shear Stress Affects the Expression of Transient Receptor Potential Channels in Human Endothelial Cells. Hypertension 2012; 59:1232-40. [DOI: 10.1161/hypertensionaha.111.183608] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Florian Thilo
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Bernd J. Vorderwülbecke
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Alex Marki
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Katharina Krueger
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Ying Liu
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Daniel Baumunk
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Andreas Zakrzewicz
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| | - Martin Tepel
- From the Department of Nephrology (F.T., K.K.) and Shear Stress and Vascular Biology Research Group, Institute of Physiology (B.J.V., A.M., A.Z.), Charité Campus Benjamin Franklin, Berlin, Germany; Institute of Molecular Medicine, Cardiovascular and Renal Research (Y.L., M.T.), Institute of Clinical Research, Odense University Hospital and University of Southern Denmark, Odense, Denmark; Department of Urology (Y.L.), Tenth People's Hospital, Tongji University, Shanghai, China; Department of Urology
| |
Collapse
|
8
|
Li J, Xin J, Hao S, Zhang L, Jiang L, Chen D, Xie Q, Xu W, Cao H, Li L. Return of the metabolic trajectory to the original area after human bone marrow mesenchymal stem cell transplantation for the treatment of fulminant hepatic failure. J Proteome Res 2012; 11:3414-22. [PMID: 22582960 DOI: 10.1021/pr3002639] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
Our recent study first demonstrated that human bone marrow mesenchymal stem cell (hBMSC) transplantation could prevent death from fulminant hepatic failure (FHF) in pigs. To further clarify the metabolic mechanism of hBMSC transplantation in FHF, the plasma collected from FHF pigs that received transplantation of hBMSCs was examined using metabolic analysis to identify the key molecular markers that regulate recovery. The results showed that obvious metabolic disturbance occurred during FHF, whereas the hBMSC transplantation group showed less severe liver injury. The metabolic trajectory returns to its original state at week 3 following the hBMSC transplantation. In total, the concentration of 26 metabolites, including conjugated bile acids, phosphatidylcholines, lysophosphatidylcholines, fatty acids, amino acid and sphingomyelin, are significantly different between the FHF group and the hBMSC transplantation group. Moreover, the time course of changes in the metabolites corresponded with that of the biochemical and histological analyses. Real-time PCR further confirmed that the gene expression of phospholipase A1, lecithin-cholesterol acyltransferase and lysophosphatidylcholine acyltransferase 1 decreased significantly, whereas that of phospholipase A2 remained stable, which explains the decrease of the phosphatidylcholines and lysophosphatidylcholines. These novel results have revealed a metabolic mechanism for the hBMSC transplantation in FHF, which could lead to the future development of treatment strategies for stem cell therapies.
Collapse
Affiliation(s)
- Jun Li
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital, College of Medicine, Zhejiang University , 79 Qingchun Rd., Hangzhou 310003, China
| | | | | | | | | | | | | | | | | | | |
Collapse
|